| Trial ID: | L2429 |
| Source ID: | NCT01444248
|
| Associated Drug: |
Glimepiride/ Metformin
|
| Title: |
Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Glimepiride/ Metformin|DRUG: Glimepiride/ Metformin
|
| Outcome Measures: |
Primary: compliance of patients treated with once-daily or twice-daily, 24 weeks | Secondary: Blood glucose lowering effect, 24 weeks|Episodes of hypoglycaemia, 24 weeks|other adverse events, 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Handok Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
168
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2010-08
|
| Completion Date: |
2012-05
|
| Results First Posted: |
|
| Last Update Posted: |
2012-08-23
|
| Locations: |
Handok Pharmaceuticals, Seoul, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01444248
|
